Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Phase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-Cell Lymphoma
Leo I. Gordon,Jason B. Kaplan,Rakesh Popat,Howard A. Burris,Silvia Ferrari,Sumit Madan,Manish R. Patel,Giuseppe Gritti,Dima El-Sharkawi,Ian Chau,John A. Radford,Jaime Pérez de Oteyza,Pier Luigi Zinzani,Swaminathan Iyer,William Townsend,Reem Karmali,Harry Miao,Igor Proscurshim,Shining Wang,Yujun Wu,Kate Stumpo,Yaping Shou,Cecilia Carpio,Francesc Bosch
Clinical Cancer Research.2020;26(14)3546
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal